文献速递肥胖与代谢综合征

肥胖患者肾小球滤过率估算方法的评估

Assessment of GFR Estimation Methods in Patients With Obesity.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该研究以血浆碘海醇清除率测得的mGFR为参考标准,在超重或肥胖患者队列中比较非索引EKFC方程、2021 CKD-EPI方程及机器学习模型的eGFR表现。结果显示非索引EKFC方程中位偏差最大(-4.80 mL/min),与mGFR一致性低于CKD-EPI 2021和ML模型,在肥胖患者CKD分期中准确性最差。

要点

  • 非索引EKFC方程在超重或肥胖患者中中位偏差最大,达-4.80 mL/min。
  • EKFC方程与mGFR一致性低于CKD-EPI 2021方程和机器学习模型。
  • 肥胖患者尤其高滤过者中,EKFC方程CKD分期准确性最差。

核心结论

  • 在超重或肥胖患者中,EKFC方程表现劣于ML模型和CKD-EPI 2021方程。
  • 需在该人群中优化GFR估算模型并在更大更多样化队列中验证。

研究设计与样本

  • 以血浆碘海醇清除率测得的mGFR为参考标准,在超重或肥胖患者队列中比较各eGFR方法。
  • 计算各方法的中位偏差(eGFR减mGFR)和一致性相关系数。

主要发现

  • 非索引EKFC方程中位偏差为-4.80 mL/min(95%CI:-7.49至-2.92)。
  • 超重患者中位偏差为-7.81 mL/min(95%CI:-12.87至-4.80),肥胖患者为-4.57 mL/min(95%CI:-8.57至-1.72)。
  • 健康BMI个体中位偏差为-2.50 mL/min(95%CI:-6.85至2.23)。
  • EKFC方程与mGFR一致性低于CKD-EPI 2021方程和ML模型。
  • 肥胖患者尤其高滤过者中,EKFC方程CKD分期准确性最差。

临床怎么用

  • 超重或肥胖患者评估GFR时,应注意EKFC方程偏差较大,CKD分期需谨慎。
  • 可优先考虑CKD-EPI 2021方程或ML模型,但需知晓其在欧洲人群中的局限性。

局限性

  • CKD-EPI 2021方程在欧洲人群中存在局限性。
  • 研究队列规模及多样性有限,需更大更多样化队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Obesity is an independent risk factor for chronic kidney disease, and accurate estimation of the glomerular filtration rate (GFR) is crucial. However, limited data are available on the performance of the European Kidney Function Consortium (EKFC) equation in individuals with overweight or obesity. OBJECTIVE: To evaluate the performance of the EKFC equation by comparing its estimated GFR (eGFR) to values obtained from the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and machine learning (ML) models. METHODS: We compared the models using measured GFR (mGFR, obtained via plasma iohexol clearance) as a reference standard in a cohort of patients with overweight or obesity. We calculated the median bias (eGFR minus mGFR) and the concordance correlation coefficient for each method. RESULTS: The non-indexed EKFC equation exhibited the highest median bias (-4.80 mL/min, 95% CI: -7.49 to -2.92), particularly in patients with overweight (-7.81 mL/min, 95% CI: -12.87 to -4.80) and obesity (-4.57 mL/min, 95% CI: -8.57 to -1.72), with lower bias in healthy BMI individuals (-2.50 mL/min, 95% CI: -6.85 to 2.23). The EKFC equation showed lower concordance with mGFR than both the CKD-EPI 2021 equation and ML models and was the least accurate for CKD stage classification in patients with obesity, particularly those with hyperfiltration. CONCLUSION: In patients with overweight or obesity, the EKFC equation performed worse than the ML-based models and the CKD-EPI 2021 equation despite limitations of the latter in European populations. Our findings highlight the need for more accurate GFR estimation in this population, optimization of these models, and their validation in larger, more diverse cohorts.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hage M, Naja M, Kaneza EB, et al. Assessment of GFR Estimation Methods in Patients With Obesity. J Clin Endocrinol Metab. 2026. PMID: 40930519. doi:10.1210/clinem/dgaf510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。